Thx Dew. I have a position in FATE and will do some DD on BEAM
Those I knew in the field had concerns about off target affects ....but maybe they ( BEAM ? ) have overcome / reduced those risks . FATE seems focused on Oncology applications and CRSP on sickle cell ... from memory .
Dew ... I’m not an MD .. just by accident ( soccer moms / dads etc ) know people working in this area in SF / Silicon Valley Biotech Kiwi
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.